|
| Press Releases |
|
 |
|
| Friday, November 15, 2019 |
|
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
| Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
| Tuesday, October 29, 2019 |
|
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
| SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
| Wednesday, July 24, 2019 |
|
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
| Wednesday, June 12, 2019 |
|
|
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing |
| SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that its U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours. more info >> |
|
| Monday, January 28, 2019 |
|
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
| Wednesday, November 7, 2018 |
|
|
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018 |
| Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California. more info >> |
|
| Monday, June 18, 2018 |
|
|
Singapore eDevelopment Limited Announces Corporate and Business Update |
| The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations. more info >> |
|
| Thursday, May 31, 2018 |
|
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar |
| Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market. more info >> |
|
| Thursday, March 1, 2018 |
|
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola |
| Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker. more info >> |
|
| Wednesday, November 1, 2017 |
|
|
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance |
| SGX-listed Singapore eDevelopment Ltd (SeD) announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Thailand RISE Fund Positions Thai Research for Global Innovation Impact
Mar 4, 2026 14:59 HKT/SGT
|
|
|
51Sim獨占半壁江山：中國高階智駕仿真市場的「一超」格局與未來啟示
Mar 4, 2026 14:31 HKT/SGT
|
|
|
51Sim独占半壁江山：中国高阶智驾仿真市场的“一超”格局与未来启示
Mar 4, 2026 14:11 HKT/SGT
|
|
|
三菱重工取締役社長 CEO 伊藤 栄作がForbes JAPAN「CIO AWARD 2025-2026」グランプリを受賞
Mar 4, 2026 14:00: JST
|
|
|
MMG Announces 2025 Anuual Results, Record results, strong momentum
Mar 4, 2026 13:34 HKT/SGT
|
|
|
OMP推出決策導向規劃方案 加速供應鏈決策速度
Mar 4, 2026 13:34 HKT/SGT
|
|
|
OMP Unveils Decision-Centric Planning to Accelerate Supply Chain Decision Velocity
Mar 4, 2026 13:33 HKT/SGT
|
|
|
JCB, together with Resona, Realize a New Purchasing Experience: The World's First Full-Scale Project to Commercialize Ultra-Wideband (UWB) Payments
Mar 4, 2026 10:00 JST
|
|
|
OMP推出决策导向型规划方案，加速供应链决策速度
Mar 3, 2026 21:00 HKT/SGT
|
|
|
TANAKA Establishes Transfer Technology for its Sintered Gold (Au) Bonding Technology "AuRoFUSE(TM) Preforms"
Mar 3, 2026 22:00 JST
|
|
|
五礦資源公佈2025年年度業績 業績創歷史新高 發展動能強勁
Mar 3, 2026 20:18 HKT/SGT
|
|
|
五矿资源公布2025年年度业绩 业绩创历史新高 发展动能强劲
Mar 3, 2026 20:18 HKT/SGT
|
|
|
Fujitsu and BCN Port Innovation Foundation leverage ocean digital twin technology to drive the regeneration of the Port of Barcelona
Mar 3, 2026 21:00 JST
|
|
|
MiniMax官宣向AI平台型公司邁進 ARR超1.5億美金夯實底盤
Mar 3, 2026 18:25 HKT/SGT
|
|
|
MiniMax官宣向AI平台型公司迈进 ARR超1.5亿美金夯实底盘
Mar 3, 2026 18:20 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
